Clinical trial
ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
NCT00493506 · Health Enhancement Products, Inc., Industry · Completed
Key facts
| NCT number | NCT00493506 |
|---|---|
| Title | ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency |
| Official title | The Effects of ProAlgaZyme Novel Algae Infusion Alone or in Combination With HAART on Markers of Immune Status, Dyslipidemia, Inflammation and Oxidative Stress in HIV or HIV/HBV Patients |
| Lead sponsor | Health Enhancement Products, Inc., Industry |
| Collaborators | University of Yaounde |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis B, Dyslipidemia |
| Intervention type | Drug |
| Interventions | ProAlgaZyme |
| Enrollment | 59 |
| Start date | May 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jun 28, 2007 |
| Last update posted | Jun 28, 2007 |
| Countries | Cameroon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: